CLINICAL TRIALS PROFILE FOR PRX-03140

Clinical Trials for PRX-03140

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00384423 ↗	Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept	Completed	Epix Pharmaceuticals, Inc.	Phase 2	This is a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PRX-03140 administered orally once daily for 14 days in subjects with mild Alzheimer's Disease who are using a stable, well-tolerated 10 mg dose of Aricept (donepezil) but continue to experience worsening AD symptoms.
NCT00672945 ↗	A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil	Terminated	Epix Pharmaceuticals, Inc.	Phase 2	A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 in subjects with Alzheimer's Disease receiving a stable dose of donepezil. The study consists of a 26-week double-blind treatment period.
NCT00693004 ↗	Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease	Terminated	Epix Pharmaceuticals, Inc.	Phase 2	A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 monotherapy in subjects with Alzheimer's disease. The study consists of a 3-month double-blind treatment period and an optional 3-month extension period.
NCT01492699 ↗	Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder	Completed	Nanotherapeutics, Inc.	N/A	This is a clinical study for adult subjects with Post Traumatic Stress Disorder.
NCT01492699 ↗	Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder	Completed	Ology Bioservices	N/A	This is a clinical study for adult subjects with Post Traumatic Stress Disorder.

Clinical Trial Conditions for PRX-03140

Condition Name

Condition Name
Intervention	Trials
Alzheimer's Disease	3
Post Traumatic Stress Disorder	1

Condition MeSH

Condition MeSH
Intervention	Trials
Alzheimer Disease	3
Stress Disorders, Traumatic	1
Stress Disorders, Post-Traumatic	1
Disease	1

Clinical Trial Locations for PRX-03140

Trials by Country

Trials by Country
Location	Trials
United States	44

Trials by US State

Trials by US State
Location	Trials
Florida	4
Oklahoma	3
Ohio	3
Massachusetts	3
Louisiana	3

Clinical Trial Progress for PRX-03140

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 2	3
N/A	1

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Terminated	2
Completed	2

Clinical Trial Sponsors for PRX-03140

Sponsor Name

Sponsor Name
Sponsor	Trials
Epix Pharmaceuticals, Inc.	3
Nanotherapeutics, Inc.	1
Ology Bioservices	1

Sponsor Type

Sponsor Type
Sponsor	Trials
Industry	5